Sign in

Thomson Reuters Corporation TRI

Price 111.8 USD
as of 2026-09-04
51/100
Weak
Quality68
Growth38
Balance-sheet strength64
Valuation41
Momentum33
Income53

Composite 51/100; the shares have moved about 53% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 33/100 — a moderate mark against it.

Case for

Quality ranks 68/100 — a moderate point in its favour. Balance-sheet strength ranks 64/100 — a moderate point in its favour. Income ranks 53/100 — a slight point in its favour.

Case against

Momentum ranks 33/100 — a moderate mark against it. Growth ranks 38/100 — a moderate mark against it. Valuation ranks 41/100 — a slight mark against it.

What the company does Thomson Reuters (TRI) provides specialized content, workflow tools, and analytics to legal, tax, accounting, corporate, and media markets across five segments: Legal Professionals, Corporates, Tax & Accounting, Reuters News, and Global Print.

Key financials TRI posts ROE 12.7%, ROA 6.9%, ROCE 15.0%, gross/operating/net margins of 39.5%/30.3%/19.9%, revenue growth 9.8%, EPS growth 5.6%, and dividend yield 2.3% with a 71.3% payout ratio.

Stock health Quality score 60.9 and income score 71.4 are positives, but momentum score 20.8 and 12-month return -48.71% signal weak performance; RSI(14) 57.60 indicates neutral technicals.

Price vs fair value The stock trades at a discount versus our fair-value estimate and analyst target. - Earnings expected to grow ahead of next release (Zacks 2026-07-29) - Reuters News segment faces competitive pressure from real-time data providers - Analyst 12-month target 120.17 implies 21.59% upside (analyst count 12.0) - Fair-value estimate 115.78 implies 17.10% upside

Looking forward Forward P/E 23.64 and PEG 1.17 suggest moderate valuation relative to growth; debt/equity 0.23 and interest coverage 13.40 indicate manageable leverage.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.